Overall rank by patents
#2,853
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Second Sight Medical Products, Inc.
USPTO PatentsView assignee record — 135 granted patents across 29 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
135
Total patents granted
29
CPC technology areas
12.2
Avg claims per patent
-82%
5-year filing velocity
The verdict
Second holds 135 US patents across 29 technology areas — rank #2,853 of 50,000 tracked assignees.
- #2,853
- of 50,000 US assignees by volume
- Top 24%
- by Innovation Score (44.9/100)
- 12.2
- avg claims per patent
- -82%
- filing velocity, last 5 yrs
Portfolio overview
Second Sight Medical Products, Inc. has been granted 135 US utility patents between 2015 and 2024, placing Second Sight Medical Products, Inc. at rank #2,853 across all assignees tracked by PlainPatent. This portfolio spans 29 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.2 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Second Sight Medical Products, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 44.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 21 grants, compared with 114 in the 2015–2019 window — a -82% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Second Sight Medical Products, Inc.'s 12.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 29 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Second Sight Medical Products, Inc. against peers pursuing similar technology classes.
How does Second compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Second Sight Medi… ◀ 135
Second Sight Medical Products, Inc.
135 patents
What this shows Second holds 135 patents — placing it at rank #2,853 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Second's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
45 Top 24% higher than 76% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2015–2024
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 30 | 22.2% |
| 2016 | 23 | 17.0% |
| 2017 | 24 | 17.8% |
| 2018 | 27 | 20.0% |
| 2019 | 10 | 7.4% |
| 2020 | 9 | 6.7% |
| 2021 | 6 | 4.4% |
| 2022 | 5 | 3.7% |
| 2024 | 1 | 0.7% |
Which technologies does Second Sight Medical Products, Inc. patent most?
Top 15 of 29 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Second Sight Medical Products, Inc. hold?
Second Sight Medical Products, Inc. holds 135 US granted patents filed between 2015 and 2024, spanning 29 technology areas.
What is Second Sight Medical Products, Inc.'s Innovation Score?
Second Sight Medical Products, Inc. has an Innovation Score of 44.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Second Sight Medical Products, Inc. focus on?
Second Sight Medical Products, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 124 patents. The company has filed patents in 29 CPC subclasses total.
Is Second Sight Medical Products, Inc.'s patent filing rate increasing or decreasing?
Second Sight Medical Products, Inc.'s recent filing velocity is -82% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Second Sight Medical Products, Inc.'s patents?
Second Sight Medical Products, Inc.'s patents average 12.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the Second Sight Medical Products, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61N technology
Second Sight Medical Products, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Second Sight Medical Products, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
